HEALTH-2007-2.3.1-4
HEALTH-2007-2.3.1-4
4 projects · €11,979,641 total EU contribution (project-level) · 40 participating organizations · 15 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€11,979,641
Countries active
Participant organizations by country (headquarters in CORDIS).
- Netherlands (8)
- UK (8)
- Germany (3)
- DK (3)
- Spain (3)
- France (3)
- BE (2)
- Italy (2)
- CH (1)
- CZ (1)
- EL (1)
- FI (1)
- PL (1)
- PT (1)
- SI (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- ITQB2 projects · PT
- PSUD2 projects · FR
- UNIVERSITAIR MEDISCH CENTRUM GRONINGEN1 projects · NL
- Leiden University Medical Center1 projects · NL
- accelCH1 projects · CH
- AGUACURE1 projects · UK
- CODA-VAR1 projects · BE
- IDIBAPS-CERCA1 projects · ES
- TECHNICAL UNIVERSITY OF DENMARK DTU1 projects · DK
- ERASMUS MC1 projects · NL
- NSPH1 projects · EL
- ESCMID1 projects · DE
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Preventing community and nosocomial spread and infection with MRSA ST 398 - instruments for accelerated control and integrated risk management of antimicrobial resistance PILGRIM · 223050 | FP7 | €2,993,824 | €3,727,953 | Details |
Translational Research on Combating Antimicrobial Resistance TROCAR · 223031 | FP7 | €2,999,444 | €3,948,929 | Details |
CONtrol of COmmunity-acquired MRSA: Rationale and Development of counteractions CONCORD · 222718 | FP7 | €2,994,192 | €3,937,760 | Details |
The Physiological Basis of Hypervirulence in Clostridium difficile: a Prerequisite for Effective Infection Control HYPERDIFF · 223585 | FP7 | €2,992,181 | €3,940,839 | Details |